Business · 08/05/2025Updated: 10/17/2026 · 1 min read
FDA Announces Public Advisory Committee Meeting for COVID-19 Vaccine Formula
Summary
The FDA is establishing a public docket for public comment on the selection of the 2025-2026 Formula for COVID-19 vaccines for use in the United States, following a forthcoming meeting of the Vaccines and Related Biological Products Advisory Committee.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →